Randomised trial shows intravenous iron significantly improves maternal haemoglobin before delivery in non-anaemic iron ...
Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from the spring 2018 visit suggested anemia, of which ...
Despite decades of iron supplementation programmes, the iron deficiency continues to affect nearly one in two women of ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from that spring 2018 medical visit suggested ...
Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.
During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue. Objectives: Medicare Part B payment ...
Gov. Larry Hogan recently announced a four-year, $72 million program to support maternal and child health with an emphasis on prevention and early intervention. “By investing in access to prenatal ...
Leukemoid reaction, a non-malignant leucocytosis (total leucocyte count≥30 000–50 000 /mm³) is typically triggered by infection, malignancy or drug exposure. Its occurrence after intravenous iron ...
With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results